Update of CVM's What's New - FDA Announces Implementation of GFI #213, Outlines Continuing Efforts to Address Antimicrobial Resistance

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Update of CVM's What's New - FDA Announces Implementation of GFI #213, Outlines Continuing Efforts to Address Antimicrobial Resistance

FDA Announces Implementation of GFI #213, Outlines Continuing Efforts to Address Antimicrobial Resistance

Today, the U.S. Food and Drug Administration announced that it has completed the implementation of Guidance for Industry #213, a process begun in 2013 to transition antimicrobial drugs with importance in human medicine (medically important antimicrobials) that are used in the feed or drinking water of food-producing animals to veterinary oversight and eliminate the use of these products in animals for production (e.g., growth promotion) purposes.

Read more.

More Animal Health Topics

 

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@xxxxxxxxxx

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)